BDX

MKT CAP:$40B

Becton Dickinson and Company

Market Cap

$40B

Healthcare·Medical Instruments & Supplies·🇺🇸 United States·NYSE

Healthcare·Medical·🇺🇸·NYSE

Stock Price

$149.99-$2.29 (-1.51%)

Jun 8, 2026

52W High $184.2152W Low $130.15

Company Details

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutica...

CEO

—

IPO Date

Jan 1, 1987

Website

www.bd.com

Key Metrics TTM

Revenue

$21.4B

+2.4% YoY

Net Income

$1.1B

EPS (Diluted)

Free Cash Flow

$3.1B

Revenue / Share

$76.13

Gross Margin

46.5%

Operating Margin

10.6%

Net Margin

5.3%

FCF Margin

14.7%

P/S

1.9x

P/E

35.2x

Earnings Reports

Q3 2026

Aug 6, 2026

PENDING

Q2 2026

May 7, 2026

$4.7B-10.6%

Q1 2026

Feb 9, 2026

$5.3B+1.6%

FY 2025

Nov 25, 2025

$21.8B+8.2%

Q4 2025

Nov 25, 2025

$5.9B+8.3%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee